-+ 0.00%
-+ 0.00%
-+ 0.00%

TG Therapeutics Q4 Earnings Assessment

Benzinga·02/26/2026 12:04:47
Listen to the news

TG Therapeutics (NASDAQ:TGTX) released its Q4 earnings on Thursday, February 26, 2026 at 07:00 AM.

Here's what's important from the earnings announcement.

Earnings

TG Therapeutics missed estimated earnings by -58.82%, reporting an EPS of $0.14 versus an estimate of $0.34.

Revenue was up $84.39 million from the same period last year.

Overview of Past Earnings

Last quarter the company beat on EPS by $2.21 which was followed by a 0.36% increase in the share price the next day.

Here's a look at TG Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.22 0.30 0.17 0.08
EPS Actual 2.43 0.17 0.03 0.15
Revenue Estimate 151.57M 142.18M 117.86M 98.54M
Revenue Actual 161.71M 141.15M 120.86M 108.19M

To track all earnings releases for TG Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.